Nvidia doesn’t have a monopoly in AI — though it sure seems that way
Pricing power and lack of competition are driving Nvidia’s growth, but rivals are gaining traction.
Regeneron accused of ‘fraudulent’ drug-pricing reporting for eye drug Eylea
The Department of Justice on Wednesday accused drug maker Regeneron Pharmaceuticals Inc. of fraudulent practices related the pricing of its blockbuster vision-impairment drug Eylea, boosting...
Rent the Runway sees ‘milestone’ 2024 and breakeven cash flow, as stock soars
Rent the Runway Inc. on Wednesday said it expected breakeven free cash flow this year, following cost cuts and signs of a revival in shoppers’...
Honest Co. shares dip 7% after Jessica Alba steps down from company she founded
Shares of Honest Co. fell Wednesday after it lost rights to use the name and likeness of founder Jessica Alba.
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion
Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue...
Boeing needs to focus on solutions, not shareholders
The aerospace giant’s self-inflicted woes hold broader lessons on how to run a company.
Nvidia’s stock has had a killer run. Why it’s still Morgan Stanley’s top AI-chip pick.
Nvidia’s $2.2 trillion market cap, once seen as “unfathomable,” could head even higher, according to Morgan Stanley.
Costco boosts its dividend by 14% while touting sharp rise in e-commerce sales
Costco saw a 9.4% sales boost the five weeks through April 7, driven by a surge in e-commerce activity. .
Hotter inflation means the stock-market rally faces a critical test as earnings season begins
Investors are abandoning bets that the Federal Reserve will cut interest rates three times in 2024, removing a critical safety net for stocks.